Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 36, n° 6
pages 914-918 (juin 1997)
Doi : 10.1016/S0190-9622(97)80272-1
accepted : 23 December 1996
Brief communication

Utility of a standard allergen series alone in the evaluation of allergic contact dermatitis: A retrospective study of 732 patients
 

David E. Cohen, MD MPH a, , Ronald Brancaccio, MD a, Dina Andersen, MD a, Donald V. Belsito, MD b
a The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA 
b Division of Dermatology, The University of Kansas Medical Center, Kansas City, Kansas, USA 

*Reprint requests: David E. Cohen, MD, MPH, Department of Dermatology, New York University Medical Center, 530 Fast Avenue H-100, New York, NY 10016.
Abstract
Background:

Patch testing remains the standard for the diagnosis of allergic contact dermatitis. The validity and usefulness of a standard patch test allergen series has not been addressed adequately by previous studies.

Objective:

We sought to examine the utility of the standard allergen series as a sole screening tool in the diagnosis of allergic contact dermatitis.

Methods:

The charts of 732 patients referred for patch testing were reviewed for positive patch test results. The group of patients with positive reactions was stratified into two groups based on the clinical relevance of their reactions. These groups were subsequently analyzed to determine whether the reactions were to part of the standard series of allergens or to part of a supplementary group.

Results:

Of patients tested, 50% had a positive patch test. Of those, 221 (30%) had reactions deemed clinically relevant. Only 23% of patients with positive patch tests reacted to an allergen(s) in the standard series exclusively. When adjusted for clinical relevance, only 15.7% of patients were completely evaluated with the standard series of 20 allergens.

Conclusion:

The standard allergen series of 20 allergens available in the United States is limited as a screening tool when used alone in the evaluation of patients with allergic contact dermatitis.

The full text of this article is available in PDF format.

Top of the page

© 1997  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@